BIOLOTEGACC — MERGEN RESEARCH SRL (Q2023771): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Removed claims)
(‎Changed an Item: The budget was changed)
Property / budget
 
623,806.6 Euro
Amount623,806.6 Euro
UnitEuro
Property / budget: 623,806.6 Euro / rank
 
Normal rank
Property / EU contribution
 
467,854.94 Euro
Amount467,854.94 Euro
UnitEuro
Property / EU contribution: 467,854.94 Euro / rank
 
Normal rank
Property / co-financing rate
 
75.0 percent
Amount75.0 percent
Unitpercent
Property / co-financing rate: 75.0 percent / rank
 
Normal rank

Revision as of 15:46, 12 February 2022

Project Q2023771 in Italy
Language Label Description Also known as
English
BIOLOTEGACC — MERGEN RESEARCH SRL
Project Q2023771 in Italy

    Statements

    country
    Italy
    0 references
    EU contribution
    467,854.94 Euro
    0 references
    budget
    623,806.6 Euro
    0 references
    co-financing rate
    75.0 percent
    0 references
    start time
    22 October 2017
    0 references
    expected end time
    16 October 2019
    0 references
    beneficiary name (string)
    ISTITUTO NAZIONALE TUMORI IRCCS FONDAZIONE SENATORE G. PASCALE
    0 references
    MERIGEN RESEARCH SOCIETA' A RESPONSABILITA' LIMITATA
    0 references
    beneficiary
    Q278445
    0 references
    Q278494
    0 references
    programme
    Campania - ERDF
    0 references
    coordinate location

    40°50'9.35"N, 14°14'55.61"E
    0 references
    summary
    BIOMOLTEACC - MERIGEN RESEARCH SRL - PROGETTI TRASFERIMENTO TECNOLOGICO E DI PRIMA INDUSTRIALIZZAZIONE PER LE IMPRESE INNOVATIVE AD ALTO POTENZIALE PER LA LOTTA ALLE PATOLOGIE ONCOLOGICHE (Italian)
    0 references
    BIOLEDACC — MERGEN RESEARCH SRL — TECHNOLOGY TRANSFER AND FIRST INDUSTRIALISATION PROJECTS FOR INNOVATIVE HIGH-POTENTIAL COMPANIES TO FIGHT CANCER DISEASES (English)
    0 references
    BIOMOLTEACC — RECHERCHE MERIGEN SRL — TRANSFERT DE TECHNOLOGIE ET PREMIERS PROJETS D’INDUSTRIALISATION POUR LES ENTREPRISES INNOVANTES À FORT POTENTIEL DE LUTTE CONTRE LES MALADIES CANCÉREUSES (French)
    point in time
    14 December 2021
    0 references
    BIOMOLTEACC — MERIGEN ONDERZOEK SRL — TECHNOLOGIEOVERDRACHT EN EERSTE INDUSTRIALISATIEPROJECTEN VOOR INNOVATIEVE BEDRIJVEN MET EEN HOOG POTENTIEEL VOOR DE BESTRIJDING VAN KANKERZIEKTEN (Dutch)
    point in time
    23 December 2021
    0 references
    BIOMOLTEACC – MERIGEN RESEARCH SRL – TECHNOLOGIETRANSFER UND ERSTE INDUSTRIALISIERUNGSPROJEKTE FÜR INNOVATIVE UNTERNEHMEN MIT HOHEM POTENZIAL ZUR BEKÄMPFUNG VON KREBSERKRANKUNGEN (German)
    point in time
    24 December 2021
    0 references
    BIOMOLTEACC — MERIGEN RESEARCH SRL — TRANSFERENCIA DE TECNOLOGÍA Y PRIMEROS PROYECTOS DE INDUSTRIALIZACIÓN PARA EMPRESAS INNOVADORAS CON ALTO POTENCIAL PARA LA LUCHA CONTRA LAS ENFERMEDADES CANCERÍGENAS (Spanish)
    point in time
    24 January 2022
    0 references
    location (string)
    NAPOLI
    0 references

    Identifiers

    Italian Unique Project Code
    B63D18000220007
    0 references
     
    Retrieved from "https://linkedopendata.eu/w/index.php?title=Item:Q2023771&oldid=27913024"